Ingle JN - Search Results

1

A phase I study of chlorozotocin (NSC 178248).

Kovach JS, Moertel CG, Schutt AJ, Frytak S, O'Connell MJ, Rubin J, Ingle JN. Kovach JS, et al. Among authors: ingle jn. Cancer. 1979 Jun;43(6):2189-96. doi: 10.1002/1097-0142(197906)43:6<2189::aid-cncr2820430605>3.0.co;2-#. Cancer. 1979. PMID: 156580

2

Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.

Creagan ET, Eagan RT, Fleming TR, Frytak S, Kvols LK, Ingle JN. Creagan ET, et al. Among authors: ingle jn. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2105-6. Cancer Treat Rep. 1979. PMID: 230898 No abstract available.

3

Evaluation of a fixed alternating treatment in patients with advanced breast cancer.

Ahmann DL, O'Fallon J, O'Connell MJ, Bisel HF, Hahn RG, Frytak S, Edmonson JH, Rubin J, Ingle JN, Kvols LK. Ahmann DL, et al. Among authors: ingle jn. Cancer Clin Trials. 1978 Fall;1(3):219-26. Cancer Clin Trials. 1978. PMID: 391427 Clinical Trial.

4

Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.

Britell JC, Ahmann DL, Bisel HF, Frytak S, Ingle JN, Rubin J, O'Fallon JR. Britell JC, et al. Among authors: ingle jn. Cancer Clin Trials. 1979 Winter;2(4):345-50. Cancer Clin Trials. 1979. PMID: 394870 Clinical Trial.

5

Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communication.

Eagan RT, Ingle JN, Rubin J, Frytak S, Moertel CG. Eagan RT, et al. Among authors: ingle jn. J Natl Cancer Inst. 1978 Jan;60(1):93-6. doi: 10.1093/jnci/60.1.93. J Natl Cancer Inst. 1978. PMID: 628025

6

Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.

Nichols WC, Kvols LK, Ingle JN, Edmonson JH, Ahmann DL, Rubin J, O'Connell MJ. Nichols WC, et al. Among authors: ingle jn. Cancer Treat Rep. 1978 May;62(5):837-9. Cancer Treat Rep. 1978. PMID: 657166 Clinical Trial.

7

Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer.

Creagan ET, O'Fallon JR, Woods JE, Ingle JN, Schutt AJ, Nichols WC. Creagan ET, et al. Among authors: ingle jn. Cancer. 1983 Jun 1;51(11):2020-3. doi: 10.1002/1097-0142(19830601)51:11<2020::aid-cncr2820511110>3.0.co;2-x. Cancer. 1983. PMID: 6682349

8

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.

Eagan RT, Frytak S, Creagan ET, Ingle JN, Kvols LK, Coles DT. Eagan RT, et al. Among authors: ingle jn. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1589-91. Cancer Treat Rep. 1979. PMID: 227597 No abstract available.

9

Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.

Ingle JN, Ahmann DL, O'Fallon JR, Bisel HF, Rubin J, Kvols LK, Giuliani ER. Ingle JN, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1701-5. Cancer Treat Rep. 1979. PMID: 526908 Clinical Trial.

10

cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.

Britell JC, Eagan RT, Ingle JN, Creagen ET, Rubin J, Frytak S. Britell JC, et al. Among authors: ingle jn. Cancer Treat Rep. 1978 Aug;62(8):1207-10. Cancer Treat Rep. 1978. PMID: 688256 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters